Intravenous Bisphosphonates for Postmenopausal Osteoporosis
<strong><span style="line-height: 200%; font-size: 12pt"><font face="Times New Roman">Abstract</font></span></strong><font face="Times New Roman"><span style="l...
Main Author: | Peyman Mottaghi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2010-01-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://journals.mui.ac.ir/jrms/article/view/4022 |
Similar Items
-
Intravenous bisphosphonates for postmenopausal osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01) -
Osteoporosis in women in menopause/postmenopause: what to do?
by: E. V. Kulchavenya, et al.
Published: (2021-01-01) -
Open, Prospective, Multi-Center, Two-Part Study of Patient Preference with Monthly Ibandronate Therapy in Women with Postmenopausal Osteoporosis Switched From Daily or Weekly Alendronate or Risendronate-BONCURE: Results of Turkish Sub-Study
by: Nurten Eskiyurt, et al.
Published: (2012-04-01) -
First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
by: Vishal R Tandon, et al.
Published: (2014-01-01) -
Long-Term Use of Bonviva® for the Treatment of Postmenopausal Osteoporosis: New Evidence
by: O.B. Yershova, et al.
Published: (2013-02-01)